Coherus BioSciences, Inc.·4

Mar 29, 4:30 PM ET

McMichael Bryan J 4

4 · Coherus BioSciences, Inc. · Filed Mar 29, 2023

Insider Transaction Report

Form 4
Period: 2023-03-27
McMichael Bryan J
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-27+25,00025,000 total
    Exercise: $6.00Exp: 2033-03-27Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]1. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary